Developing vaccines to fight antibiotic-resistant bacteria
Advanced Development of Vaccines for Antibiotic Resistant Bacteria
['FUNDING_OTHER'] · EVELIQURE BIOTECHNOLOGIES, GMBH · NIH-10880209
This study is working on developing vaccines to help protect people from infections caused by bacteria that don't respond to regular antibiotics, and it's aimed at making sure these vaccines are safe and effective for future use in humans.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EVELIQURE BIOTECHNOLOGIES, GMBH (nih funded) |
| Locations | 1 site (VEINNA, AUSTRIA) |
| Trial ID | NIH-10880209 on ClinicalTrials.gov |
What this research studies
This research focuses on creating vaccines to combat infections caused by antibiotic-resistant bacteria, particularly in response to outbreaks. It involves formulating and manufacturing vaccine components, conducting stability tests, and evaluating their effectiveness and safety in animal models. The ultimate goal is to prepare these vaccines for clinical trials to ensure they are safe and effective for human use.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk of infections from antibiotic-resistant bacteria, including those with weakened immune systems or underlying health conditions.
Not a fit: Patients who are not at risk of antibiotic-resistant infections or those who are already infected with such bacteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to effective vaccines that protect patients from serious infections caused by antibiotic-resistant bacteria.
How similar studies have performed: Other research has shown promise in developing vaccines for infectious diseases, but this specific approach targeting antibiotic-resistant bacteria is relatively novel.
Where this research is happening
VEINNA, AUSTRIA
- EVELIQURE BIOTECHNOLOGIES, GMBH — VEINNA, AUSTRIA (ACTIVE)
Researchers
- Principal investigator: MALINOWSKI, FRANK — EVELIQURE BIOTECHNOLOGIES, GMBH
- Study coordinator: MALINOWSKI, FRANK
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Communicable Diseases, Infectious Disease Pathway, Infectious Diseases, Infectious Disorder, Disease Outbreaks